From: Bladder cancer index: cross-cultural adaptation into Spanish and psychometric evaluation
N (%) | |
---|---|
Total patients | 197 |
Age | |
Mean (standard deviation) | 69.3 (11) |
Sex | |
Male | 171 (86.8) |
Female | 26 (13.2) |
Tumor histology | |
Adenocarcinoma | 17 (10.2) |
Transitional cell carcinoma | 116 (69.9) |
Squamous-cell carcinoma | 3 (1.8) |
Others | 30 (18.1) |
Missing | 31 (15.7) |
Disease stage | |
Tx | 5 (2.5) |
Ta | 58 (29.4) |
Tis | 5 (2.5) |
T1 | 102 (51.8) |
T2a | 16 (8.1) |
T2b | 6 (3.0) |
T3 | 3 (1.5) |
T4 | 2 (1.0) |
Missing | 11 (5.6) |
Medical treatment | |
Transurethral resection | 183 (96.3) |
Radical cystectomy | 6 (3.2) |
Bacillus Calmette–Guérin | 33 (17.4) |
Chemotherapy | 24 (12.6) |
Radiotherapy | 3 (1.6) |
Missing | 7 (3.6) |
Education | |
Incomplete studies | 62 (31.5) |
Primary or secondary studies | 103 (52.6) |
Superior studies | 31 (15.9) |